Ignite Creation Date:
2025-12-26 @ 5:23 PM
Ignite Modification Date:
2026-01-22 @ 10:17 AM
Study NCT ID:
NCT01924806
Status:
TERMINATED
Last Update Posted:
2020-02-28
First Post:
2013-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Pilot Study of the WoundWand™ Debridement Device on Infection Prevention
Sponsor:
Smith & Nephew, Inc.
Organization:
Study Overview
Official Title:
A Pilot Study of the WoundWand™ Debridement Device on Infection Prevention
Status:
TERMINATED
Status Verified Date:
2020-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Lower than expected accrual rate and desire to reassess overall study strategy.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
WoundWand
Brief Summary:
A Pilot Study of the WoundWand™ Debridement Device on Infection Prevention
Detailed Description:
The primary aim of this pilot study is to investigate differences in bacterial content of the study wound that may impact upon infection rates following debridement with the WoundWand Debridement Device or Standard of Care (SoC) surgical (sharp) debridement. Additionally, the clinical investigation will evaluate reduction in wound size post-debridement and gather Health Economic data relating to wound bed debridement with the WoundWand Debridement Device or SoC.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: